Record Q4 and full-year results were driven by strong SaaS and Elite platform growth, major new healthcare wins, and operational scaling. Fiscal 2027 guidance calls for continued SaaS and EBITDA margin expansion, with growth led by new customers and expansions rather than migrations.Based on TECSYS…
Record Q4 and full-year results were driven by strong SaaS and Elite platform growth, major new healthcare wins, and operational scaling. Fiscal 2027 guidance calls for continued SaaS and EBITDA margin expansion, with growth led by new customers and expansions rather than migrations.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.